← FDA DRUG APPROVALS

FDA ANDA · ANDA211315

TRIAMCINOLONE ACETONIDE

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA211315
TYPE
ANDA
ORIGINAL APPROVAL
2020-03-18
LATEST ACTION
2020-03-18
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

TRIAMCINOLONE ACETONIDEDiscontinued
TRIAMCINOLONE ACETONIDE 0.1% · OINTMENT · TOPICAL
TRIAMCINOLONE ACETONIDEDiscontinued
TRIAMCINOLONE ACETONIDE 0.5% · OINTMENT · TOPICAL

Approval history

2020-03-18UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →